文献速递妇科

卵巢癌球体的大小和形状对耐药性和迁移的影响

The effects of size and shape of the ovarian cancer spheroids on the drug resistance and migration.
PubMed 文献 · Gynecol Oncol · 2020-09-18

研究用OVCAR-3和OVCAR-8细胞形成疏松聚集体与紧密球体,检测上皮-间质转化标志物,并给予紫杉醇和顺铂处理。结果显示耐药性不随球体大小和形状变化,而紧密球体(OVCAR-8)的迁移能力比疏松聚集体(OVCAR-3)高15倍。

要点

  • OVCAR-3形成疏松聚集体,OVCAR-8形成紧密球体,形态差异与上皮-间质转化标志物表达有关。
  • 耐药性未随球体大小和形状变化而出现差异。
  • 紧密球体(OVCAR-8)迁移能力比疏松聚集体(OVCAR-3)高15倍。

核心结论

  • 球体大小和形状影响抗癌药物耐药性和迁移特征,结果有助于阐明基于3D样本的卵巢癌研究的一般规律。

研究设计与样本

  • 用OVCAR-3和OVCAR-8细胞形成球体,以共聚焦显微镜和荧光显微镜监测形态,用蛋白质印迹法检测上皮-间质转化标志物E-钙黏蛋白、波形蛋白和Slug,并用紫杉醇和顺铂处理球体后研究迁移特征。

主要发现

  • 观察到两种不同的多细胞结构:疏松聚集体(OVCAR-3)和紧密球体(OVCAR-8)。
  • 不同形态归因于上皮-间质转化标志物的表达及其在球体形成后的变化。
  • 未观察到耐药性随球体大小和形状变化而出现差异。
  • 紧密球体(OVCAR-8)的迁移能力比疏松聚集体(OVCAR-3)高15倍。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: High fatality in ovarian cancer is attributed to metastasis, propagated by the release of multi-cellular aggregates/spheroids into the peritoneal cavity and their subsequent mesothelial invasion of peritoneal organs. Spheroids are therefore a common and clinically relevant in vitro model for ovarian cancer research. Spheroids in patients vary significantly in size and shape and display enhanced resistance to anti-cancer drugs compared to monolayers. However, there is no consensus on how spheroid size and shape affect drug resistance. Moreover, existing data regarding the influence of epithelial-to-mesenchymal transition (EMT) profile on spheroid shape and migration is inconclusive. METHODS: We formed spheroids with OVCAR-3 and OVCAR-8 cells, chosen for their established genetic similarity to the patient tumor samples. We monitored their morphology using confocal microscope with dipping objective and fluorescent microscope. We characterized important EMT biomarkers; E-cadherin, Vimentin and Slug through western blotting in monolayers and spheroids. We treated these spheroids with Taxol and Cisplatin and investigated their migratory profile based on their morphology. RESULTS: We report two distinct multicellular structures: loose aggregates (OVCAR-3) and compact spheroids (OVCAR-8). We attribute these different morphologies to the expression of the EMT biomarkers, and their changes upon spheroid formation. Importantly, we did not observe a difference in resistance to the anti-cancer drugs as a function of spheroid size and shape. However, migration capacity of compact spheroid (OVCAR-8) was 15-fold higher compared to that of loose aggregates (OVCAR-3). CONCLUSIONS: These results highlight the importance of spheroid size and shape on anti-cancer drug resistance and migration profiles. The results of this study can, therefore, help to elucidate general rules for ovarian cancer studies based on 3D samples.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Gunay G, Kirit HA, Kamatar A, et al. The effects of size and shape of the ovarian cancer spheroids on the drug resistance and migration. Gynecol Oncol. 2020. PMID: 32958270. doi:10.1016/j.ygyno.2020.09.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。